Bioverativ Inc. (BIVV) Tops Q2 EPS by 17c

Bioverativ Inc. (NASDAQ: BIVV) reported Q2 EPS of $0.88, $0.17 better than the analyst estimate of $0.71. Revenue for the quarter came in at $289.1 million versus the consensus estimate of $268 million.

For earnings history and earnings-related data on Bioverativ Inc. (BIVV) click here.

You May Also Be Interested In

• Walmart (WMT) Tops Q2 EPS by 7c, Beats on Revenue; Offers FY27 EPS Guidance
• Daqo New Energy (DQ) Misses Q2 EPS by 67c
• ATRenew Inc (RERE) Tops Q2 EPS by 8c ; Offers Guidance